Enteral nutritional supplementation prevents mesenteric lymph node T-cell suppression in burn injury.
OBJECTIVE
To determine the effects of an immune-enhancing diet supplemented with glutamine, arginine, fish oil, and dietary nucleotides on mesenteric lymph node T-cell functional disturbances encountered after burn injury in rats.


METHODS
A prospective animal study.


METHODS
University medical center research laboratory.


METHODS
Adult male Sprague-Dawley rats.


METHODS
Rats received a 30%, total body surface, full-thickness burn. Burn-injury rats received the IMPACT diet supplemented with glutamine, arginine, fish oil, and nucleotides or arginine, fish oil, and nucleotides, or an isocaloric/isonitrogenous diet without supplementation with glutamine, arginine, fish oil, or nucleotides.


RESULTS
Two days after injury, we found a significant decrease in the proliferation and interleukin-2 production by mesenteric lymph node T cells derived from rats fed on conventional chow compared with sham rats. The burn-related suppression of mesenteric lymph node T-cell proliferation and interleukin-2 production was prevented when the rats were fed on a high-protein diet rich in glutamine, arginine, fish oil, and nucleotides. We found that the immunostimulatory effects of the enriched diet are dependent on the presence of glutamine, arginine, fish oil, and nucleotides as feeding of rats on the isocaloric/isonitrogenous diet deficient in glutamine, arginine, fish oil, and nucleotides did not prevent the burn-related suppression of mesenteric lymph node T-cell dysfunction. Finally, our studies suggested that immunostimulatory effects of the diet are mediated by prostaglandin E(2) regulation of T-cell activation signaling molecule P59fyn.


CONCLUSIONS
These results suggest that a diet rich in arginine, fish oil, and nucleotides, with and without glutamine, can effectively prevent T-cell dysfunction encountered after burn injury.
Choudhry
Mashkoor A
MA
Critical Care Research Labs, Burn and Shock Trauma Institute, Department of Surgery, Loyola University/Chicago Medical Center, 2160 South First Avenue, Maywood, IL 60153, USA.
Haque
Farah
F
Khan
Mehdi
M
Fazal
Nadeem
N
Al-Ghoul
Walid
W
Ravindranath
Thyyar
T
Gamelli
Richard L
RL
Sayeed
Mohammed M
MM
D000704:Analysis of Variance; D000818:Animals; D001120:Arginine / Q000627:therapeutic use; D002056:Burns / Q000628:therapy*; D015232:Dinoprostone / Q000097:blood; D004750:Enteral Nutrition; D005395:Fish Oils / Q000627:therapeutic use; D005973:Glutamine / Q000627:therapeutic use; D007376:Interleukin-2 / Q000378:metabolism; D008198:Lymph Nodes / Q000276:immunology*; D008213:Lymphocyte Activation; D008297:Male; D008643:Mesentery; D009696:Nucleic Acids / Q000627:therapeutic use; D011518:Proto-Oncogene Proteins / Q000378:metabolism; D051076:Proto-Oncogene Proteins c-fyn; D051381:Rats; D017207:Rats, Sprague-Dawley; D013601:T-Lymphocytes / Q000378:metabolism*
D005395:Fish Oils; D007376:Interleukin-2; D009696:Nucleic Acids; D011518:Proto-Oncogene Proteins; D005973:Glutamine; D001120:Arginine; C494961:Fyn protein, rat; D051076:Proto-Oncogene Proteins c-fyn; D015232:Dinoprostone